How CareBareRX prices treatment and where its public pages conflict
CareBareRX is the consumer-facing brand for a cash-pay telehealth catalog. Its legal pages describe CareBareRX as a Delaware corporation at an Alpharetta, Georgia address. The FAQ says the program uses the CareGLP platform powered by CareValidate Inc. CareBareRX and CareValidate provide administrative and technology services rather than practicing medicine or operating a pharmacy.
The FAQ identifies Lion MD and names Ana Lisa Carr, MD, Kelly Tenbrink, MD, HirenKumar Italia, MD, and David Mansour, DO. All four listed NPIs are active in the federal registry. Their primary taxonomies include family medicine, emergency medicine, and internal medicine. Those records verify identities, not that any one physician will be assigned to a specific patient.
CareBareRX names Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx. That is useful transparency, but the catalog does not map one pharmacy to every product, formulation, or state. Product notes say secondary pharmacies may serve certain states and cost can vary, so the dispensing pharmacy still needs confirmation before payment or fulfillment.
The public homepage advertises weight-loss treatment from $199 per month, hair and sexual-health treatment from $99, and NAD+ from $199. The current official intake catalog agrees only on the lowest one-month semaglutide price. It starts hair bundles at $180, sildenafil or tadalafil tablets at $120, and NAD+ at $325. The review uses the live intake catalog because it identifies the actual product, quantity, and price.
Compounded semaglutide one-month pricing varies by listed dose: $199 at 0.25 mg, $249 at 0.5 or 1 mg, and $299 at 1.5 or 2 mg. Separate bundles cost $748 for three months, $1,268 for six months, or $2,218 for twelve. The compact card rounds the longest bundle to $185 per stated month.
Compounded tirzepatide one-month pricing is $299 at 2.5 or 5 mg, $349 at 7.5 or 10 mg, and $399 at 12.5 or 15 mg. Bundles cost $1,068 for three months, $1,918 for six months, or $3,518 for twelve. The compact card rounds the longest bundle to $293 per stated month.
The multi-month bundle descriptions are blank. CareBareRX does not say which monthly doses or quantities are included, whether the full total is charged at checkout, whether billing occurs in installments under a commitment, or how dose changes affect the amount. A low monthly average is therefore not the same as a transparent cancel-anytime monthly plan.
The brand catalog lists Ozempic at $705, Wegovy at $990, Rybelsus at $645 for 30 tablets, and Mounjaro at $835 but sold out. Wegovy has a chronic-weight-management indication for eligible patients. The displayed Ozempic and Rybelsus uses are in a weight-loss pathway even though their approved labels do not establish chronic weight management, so use solely for that purpose is off label.
CareBareRX's weight-loss page also mentions an emerging oral tirzepatide option through compounded or research-based prescribing. No orderable oral tirzepatide bundle appears in the current live catalog. The review does not turn marketing for an unavailable or undefined formulation into a therapy card.
The compounded GLP-1 listings say they use the same active ingredient as named brands and attach average weight-loss percentages from clinical trials. FDA says compounded finished products are not approved or reviewed before marketing for safety, effectiveness, or quality and warns telehealth companies against implying sameness or clinically proven equivalence. Ingredient normalization does not establish product equivalence.
The FAQ still explains semaglutide compounding primarily through drug shortages and links readers to a shortage page. Broad shortage-related enforcement periods for semaglutide and tirzepatide have ended. Patient-specific compounding may still qualify under federal law when applicable requirements are met, but the prescriber and pharmacy should explain the individual clinical need and exact formulation.
Sildenafil and tadalafil commercial tablets each start at $120 for ten tablets. Twenty tablets cost $165, thirty cost $210, and ninety cost $470. Compounded strips start at $130 for sildenafil and $155 for tadalafil. The cards consolidate tablets and strips under the canonical ingredients and use the current tablet starting price, while quantity and formulation stay visible in the notes.
NAD+ is listed at $325 for a 200 mg/mL, 10 mL quantity. The homepage's $199 starting claim is not reflected in the current catalog. NAD+ has real biochemical roles, but those roles do not prove the advertised energy, focus, mood, or healthy-aging outcomes from a specific injected compound. FDA has reported adverse events and ingredient-grade concerns involving compounded NAD+ injectables.
Sermorelin acetate is $300 for a listed 2 mg/mL, 10 mL quantity and is marketed for body composition, sleep, skin, and anti-aging goals. Those outcomes are not established by an FDA-approved adult-longevity indication. The patient should obtain the individualized rationale, dose, baseline evaluation, follow-up laboratory plan, and measurable treatment goal.
Methylcobalamin vitamin B12 is listed at $200. The catalog unusually gives the same price for 5 mg/mL in both 10 mL and 30 mL quantities. That may reflect a data error or different fulfillment rules. Deficiency, dose, vial quantity, pharmacy, route, and laboratory monitoring should be confirmed rather than inferred from the product card.
Hair treatment is deliberately not expanded into many therapy cards. The live catalog contains three topical bundles combining minoxidil, finasteride, ketoconazole, or latanoprost at $180 to $215 for the shortest supply. The editorial page separately says oral finasteride and dutasteride may be offered, but no matching live-catalog bundle and price is present. Bundle prices cannot be assigned cleanly to one ingredient.
The onboarding sequence is clear. A patient completes an online questionnaire, has a clinician consultation or review, receives a prescription decision, and receives medication by mail when appropriate. The homepage says intake review occurs within 24 hours, and the FAQ says screening tests may be ordered. Neither statement guarantees approval or one universal testing protocol.
Availability claims need reconciliation. The FAQ says CareBareRX serves all fifty states and Puerto Rico, while the terms say service is available only in certain states. Several hair, sexual-health, and longevity products exclude eleven states, and other products use secondary pharmacies that may change price. Availability should be checked by exact product, formulation, clinician, pharmacy, and state.
The FAQ estimates delivery within five to seven days after assessment and prescription and says medication is supplied monthly. CareBareRX names four possible pharmacies and describes discreet shipping. It does not publish one guaranteed pharmacy-processing window, carrier-delay procedure, cold-chain standard, temperature-excursion rule, replacement deadline, or lost-package policy.
CareBareRX publishes support@carebarerx.com, info@carebarerx.com, and 844-357-3601. The FAQ says email and phone support are included in listed prices. No public hours, response-time target, clinical escalation path, or after-hours coverage definition was found. Administrative support should not be treated as emergency or continuous clinical coverage.
The GLP-1 product descriptions say an $80 telehealth consultation fee applies if medication is not prescribed. The terms say consultation fees are nonrefundable, prescription products cannot be returned for reuse or resale, and all sales are final. No public cancellation cutoff, renewal cancellation procedure, partial-term refund rule, or multi-month exit process was found.
The current intake configuration displays code CBRX25% for pre-launch pricing even though the service is already live. It does not publish eligible products, expiration, stacking, renewal treatment, or a guaranteed discounted amount. The terms describe medical groups as out of network and warn that prescriptions and labs may not be covered, while the site separately accepts HSA and FSA cards.
- The lowest compact GLP-1 prices require twelve-month bundles: about $185 for semaglutide and $293 for tirzepatide.
- The current intake catalog is materially higher than homepage marketing for hair, sexual health, and NAD+.
- Four clinicians and four pharmacies are named, but final assignment, state access, cancellation, and compounded-product details still require confirmation.
